PRMT1 and breast cancer: Moreover, a mechanism that activates ZEB1 is the asymmetric dimethylation of H4R3 by PRMT1 at the ZEB1 promoter, which promotes migration, invasion, and the acquisition of stem cell properties of breast cancer cells [15].